Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Ambrosia Biosciences Secures $100M to Revolutionize Oral GLP-1 Obesity Treatments
Ambrosia Biosciences recently secured a massive $100 million in an oversubscribed Series B financing round. Blue Owl Healthcare Opportunities, Redmile, and Deep Track Capital co-led this pivotal investment. This backing signals strong market confidence in Ambrosia’s innovative metabolic disease treatments.…